MSB 3.06% $1.01 mesoblast limited

Ann: Submits New Information to FDA IND File for SR-aGVHD, page-119

  1. 214 Posts.
    lightbulb Created with Sketch. 156
    I'm finding it amusing the distraction of whether it's 2 weeks or 4. Seriously, who cares, after a 2 year set back. I first invested in 2014 and have built up quiet the packet of shares, enough I could start to retire when they hit $18. So whether i can retire on the 15 March 2023 or 30th March doesn't matter.
    my reading of the paperwork is that it will be classed as a class 2 submission based on what is classed as class 1. Whether it's 2015 or a later version, it's not going to be radically different. And it's just a distraction.
    do you think silviu et al are going to stuff up a resubmission when they have an ex FDA director on board and our CMO.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.01
Change
0.030(3.06%)
Mkt cap ! $1.153B
Open High Low Value Volume
$1.01 $1.04 99.0¢ $5.111M 5.050M

Buyers (Bids)

No. Vol. Price($)
2 211966 $1.01
 

Sellers (Offers)

Price($) Vol. No.
$1.02 136540 9
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.